AmadeuCarceller Guillamet

Especialitat:
Especialitats:
Hospitals on treballa:
  • Hospital Quirónsalud Barcelona
Informació general

El Dr. Amadeu Carceller Guillamet compta amb una extensa experiència en la cirurgia de la cataracta i el glaucoma. A la cirurgia de la cataracta el seu principal objectiu és implantar la lent intraocular ideal per obtenir el màxim rendiment visual de la intervenció quirúrgica, basant-se en les necessitats del pacient i les característiques òptiques del seu ull. Pioner en la implantació de lents tòriques per a la compensació de l'astigmatisme, treballa amb lents trifocals, de focus estès o monofocals de la majoria de fabricants. A la cirurgia del glaucoma el seu principal objectiu és minimitzar riscos buscant la cirurgia menys agressiva que aconsegueixi els nivells de control tensional desitjables segons el grau de lesió glaucomatosa del pacient. És expert en cirurgia de trabeculectomia, cirurgia d'esclerectomia profunda no penetrant, implants de dispositius de drenatge, cirurgia amb làser díode, implants trabeculars mínimament invasius com l'iStent inject de què és usuari des del 2010, iTrack, etc).

El Dr. Carceller ha estat el director del Servei d'Oftalmologia de l'Hospital Quirónsalud Barcelona del 2008 al 2020, quan passa a centrar-se més en l'activitat assistencial i crear la unitat d'assajos clínics. Va ser adjunt del Departament de Glaucoma de l'Hospital Universitari Vall d'Hebron de Barcelona, ​​actualment en excedència. Fou adjunt i cap de servei de l'Hospital Sagrat Cor de Barcelona.

Experiència
  • 2008-Present: Hospital Quirón Barcelona. Head of the Ophthalmology Department from 2008 to 2021. Glaucoma and Anterior Segment/Cataract specialist from 2008 to present.
  • 2006-September 2012: Consultant Ophthalmologist as Glaucoma specialist at Hospital de la Vall d’Hebron, Barcelona. Since September 2012 in exceedance.
  • 1999-2006: Hospital Universitari Sagrat Cor, Barcelona. Consultant Ophthalmologist Cataract and glaucoma specialist from 1999 to 2006. Head of the Ophthalmology Department from 2002 to 2006.

 

EXPERIENCE IN CLINICAL TRIALS AND GCP TRAINING

  • GCP Training for Site Staff course. 30th of October 2010 imparted by Dr. Sabine Köhler from ECCRT in Munich.
  • Principal Investigator at Hospital de la Vall d’Hebron of a multicenter Pilot Study about a new glaucoma surgical implant (Gold Shunt). Closed study. Study granted by the Catalan Ophthalmological Society.
  • Principal investigator in the Phase IV study: "A 2-year, multicenter, double-masked, randomized, parallel study of the safety of LUMIGAN® 0.1 mg/mL compared with LUMIGAN® 0.3 mg/mL in patients with glaucoma or ocular hypertension". Protocol number 192024-054. Study already closed.
  • GCP Course Completion 28 March 2016 (Nida Clinical trials Network).
  • Principal investigator in the Phase III Study: "A prospective, double-masked, randomized, multicenter, active- controlled, parallel-group,
  • 6-month study assessing the safety and ocular hypotensive efficacy of PG324 Ophthalmic Solution compared to GANFORT® (bimatoprost 0.03%/timolol 0.5%) Ophthalmic Solution in subjects with elevated intraocular pressure (MERCURY 3)". Protocol number PG324-CS303. Study already closed.
  • GCP Review course of ICH E6 (Version date 01-February-2017). INC Research. 7 September 2017.
  • GCP Refresher Course for all Site Personnel Working on Clinical Research Studies (including ICH E6, Revision 2 Changes). Syneos Health. 7 November 2019.
  • Participation as Ophthalmologist in more than 60 Oncological research clilnical trials (Phase I to IV).
  • Principal investigator in the Phase III Study "Efficacy and Safety Assessment of T4030 Eye Drops versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients". Protocol number LT4030-301.Ongoing study.
  • GCP Course from The Global Health Network: ICH GOOD CLINICAL PRACTICE E6 (R2). 5 February 2022.

 

AFFILIATIONS

  • Member of the Catalan Ophthalmological Society.
  • Member of the European Cataract and Refractive Society (ESCRS)
  • Member of the European Glaucoma Society (EGS)

 

Titulació
  • Bachelor of Medicine and Surgery from the Universitat de Barcelona (1988-1993). Degree awarded by the Spanish Ministry of Education and Science in 1993.
  • Specialization in Ophthalmology. Training done at Hospital de Sant Pau, Barcelona (January 1995-December 1998) as part of the Spanish residency training (MIR Programme).
  • Research Sufficiency awarded by the Universitat Autònoma de Barcelona in 1997.
  • Exam of the International Council of Ophthalmology, "The Basic Science Assessment in Ophthalmology including Optics and Refraction" passed on May 2007.
Tècniques

MAIN FIELDS OF INTEREST


As ophthalmic surgeon I have plenty of experience performing most of the glaucoma surgeries (trabeculectomy, non penetrating deep-sclerectomy, drainage devices, trabecular iStent implants, goniosinequiolysis, iTrack canaloplasty, XEN implant, cyclophotocoagulation) and Anterior Segment surgeries (Cataract surgery with special intererest in toric and multifocal IOLs, ICL, Artisan-Artiflex lenses for aphaquia, pterygium surgery with conjunctival autograft, IOLs explantation surgeries, basic oculoplastic surgeries).

I trained ophthtalmology residents at Hospital de la Vall d’Hebron during their Glaucoma rotation. Four of them have became Glaucoma Specialists as well.

I have written three book chapters (nanoftalmos, cataract surgery in glaucoma, minimally invasive glaucoma Surgery: iStent), given over 50 scientific presentations in local and international Ophthalmological Meetings and have won a first place oral communication award (Yag Iridectomy in Pigmentary glaucoma, 2007) and a first place video award (iStent implantation technique, 2011) in the Catalan Ophthalmology Society congress. I have been the director of an annual wetLab cataract surgery course focused on solving complications at Alcon-Spain from 2005 to 2016. I have coorganized and participated in many Glaucoma Courses and symposiums, as well as in live Surgery congresses and virtual congresses.

Published as co-author the article "Prospective, randomized study of one, two, or three trabecular bypass stents in open angle glaucoma subjects on topical hypotensive medication" in Clinical Ophthalmology 2015:9. And the article "Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes" in Clinical Ophthalmology 2018:1.